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Accurate case-based surveillance data remain the key 
data source for estimating HIV burden and monitoring 
prevention efforts in Europe. We carried out a literature 
review and exploratory analysis of surveillance data 
regarding two crucial issues affecting European 
surveillance for HIV: missing data and reporting delay. 
Initial screening showed substantial variability of 
these data issues, both in time and across countries. In 
terms of missing data, the CD4+ cell count is the most 
problematic variable because of the high proportion of 
missing values. In 20 of 31 countries of the European 
Union/European Economic Area (EU/EEA), CD4+ counts 
are systematically missing for all or some years. One 
of the key challenges related to reporting delays is 
that countries undertake specific one-off actions 
in effort to capture previously unreported cases, 
and that these cases are subsequently reported 
with excessive delays. Slightly different underlying 
assumptions and effectively different models may be 
required for individual countries to adjust for missing 
data and reporting delays. However, using a similar 
methodology is recommended to foster harmonisation 
and to improve the accuracy and usability of HIV 
surveillance data at national and EU/EEA levels.
Introduction
HIV remains one of the most important public health 
concerns in the European Union and European 
Economic Area (EU/EEA). Accurate data are therefore 
crucial to appropriately direct and evaluate public 
health response.
The European Centre for Disease Prevention and 
Control (ECDC) and the World Health Organization 
Regional Office for Europe (WHO/Europe) have jointly 
coordinated enhanced HIV/AIDS surveillance in the 
European Region since 2008. The general objectives 
of the surveillance system in EU/EEA countries include 
monitoring of trends over time and across countries. 
Specific HIV-related objectives include the monitoring 
of testing patterns, late HIV diagnoses, defined by low 
CD4+  counts (<350 cells/mm3), and mortality, as well 
estimating HIV incidence and prevalence stratified 
by key populations, e.g. transmission category and 
migrant status [1].
To meet these objectives, the long-term strategy 
states that improving the quality of surveillance 
data is needed [2]. Achieving this in practice poses 
challenges, especially given the heterogeneous 
national surveillance systems in the EU/EEA and 
that the routinely collected data are known to suffer 
from important quality limitations. The limitations 
originating from national data collection systems 
may include under-reporting or duplication of cases, 
delays in reporting, incompleteness of data and 
misclassification. Accounting for some of these 
limitations (e.g. assessment of under-reporting) 
requires additional data such as cohort studies or 
registries, while other issues, such as incompleteness 
and reporting delay, may be addressed directly within 
the surveillance datasets.
Missing data are a well-recognised problem within sur-
veillance systems. When values for some variables are 
missing and cases with missing values are excluded 
from analysis, it may lead to biased and potentially 
less precise estimates [3,4]. In principle, whenever 
there are missing data or reporting delays, the accuracy 
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of epidemiological distributions and trends should be 
interpreted with caution.
Reporting delay, the time from case diagnosis to notifi-
cation, can lead to problems when analysing the most 
recent years, given that the information on some cases 
or variables may not have been collected yet because 
of national reporting process characteristics. This phe-
nomenon is common in disease surveillance and also 
applies to HIV [5-8]. Rough adjustments for reporting 
delay were already implemented in the past in Europe 
[8,9], but further refinement of the existing applied 
methodology is needed to address this issue across 
more countries’ data.
The main purpose of this paper is to explore the issues 
of missing data and reporting delay in EU/EEA HIV sur-
veillance data. We aim to quantify the extent to which 
these problems are present and to identify specific data 
characteristics that are relevant for data adjustments. 
Taking these characteristics into account, we also pro-
pose methods to adjust for missing data and reporting 
delay based on literature and existing national prac-
tices in EU/EEA countries.
Methods
The analysis was based on HIV surveillance data 
from 31 EU/EEA countries uploaded to the European 
Surveillance System (TESSy) database by September 
2015 [10].
All countries, apart from Liechtenstein, described their 
surveillance system as comprehensive. In six countries 
reporting was voluntary, whereas in the others it was 
mandatory [9]. In four countries (Bulgaria, Estonia, 
Ireland and Italy) historical data covering different 
periods before 2010 were reported in aggregate format 
(n = 23,131 cases). Full national coverage was achieved 
in 2012 in Italy and in 2013 in Spain; France started HIV 
surveillance in 2003. All cases reported in case-based 
format from 1980 or from the beginning of national sur-
veillance up through 2014 were included in the analysis 
(n = 535,434 cases).
Descriptive analysis of missing values and reporting 
delay in the surveillance data was performed. In terms 
of missing values, the analysis focused on more recent 
data. For our analysis, this was defined as cases 
diagnosed in 2000 or later. It should be noted that 
some important variables, such as viral load, were 
excluded from the missing values analysis as they 
were only introduced with the 2015 revised reporting 
format and this format is not used by a percentage of 
the countries in the analysed dataset [9].
Historically, besides the year, only the quarter of the 
year of diagnosis and the quarter of notification were 
reported, and still the precise dates are not available 
for many countries. Moreover, data are uploaded to 
TESSy with a lag of two quarters, which makes short 
delays less relevant. Taking this into account, we 
defined reporting delay as the difference between the 
quarter when the case was diagnosed and the quarter 
when the case was reported. A nonparametric K-sample 
test on the equality of medians was used to compare 
the lengths of reporting delays across groups.
A consultation among the EU/EEA countries, in which 
26 of 31 countries participated, was performed to 
identify methods already in use. In addition, we per-
formed a scoping review to identify further available 
techniques, focusing on papers that reported on the 
surveillance applications. The scoping review included 
PubMed and Scopus database searches and a Google 
search using the search terms ‘missing data’/‘missing 
Table 1
Availability of CD4+ count, transmission category, migrant status, age and sex in European HIV surveillance data over 
different diagnosis periods, EU/EEA countries (n = 31), 1984–2014a
Epidemiological variables
Diagnosis year
Overall
pre-2000 2000–04 2005–08 2009–11 2012–14
n = 135,957 n = 99,418 n = 111,586 n = 92,854 n = 95,619 n = 535,434
n % n % n % n % n % n %
CD4+ count 42,801 31.5 49,359 49.6 52,926 47.4 56,277 60.6 60,329 63.1 261,692 48.9
Transmission category 121,293 89.2 87,797 88.3 94,010 84.2 77,030 83.0 78,156 81.7 458,286 85.6
Migrant status 89,671 66.0 84,23 84.7 94,198 84.4 79,548 85.7 81,993 85.7 429,649 80.2
Age 133,784 98.4 98,791 99.4 111,028 99.5 92,462 99.6 95,372 99.7 531,437 99.3
Sex 134,984 99.3 99,143 99.7 111,118 99.6 92,500 99.6 95,396 99.8 533,141 99.6
Complete records 35,158 25.9 45,165 45.4 48,865 43.8 51,545 55.5 54,292 56.8 235,025 43.9
Complete records (excluding 
CD4+count) 83,867 61.7 78,465 78.9 86,719 77.7 72,379 77.9 73,476 76.8 394,906 73.8
EEA: European Economic Area; EU: European Union.
a Case-based data were not available for all periods for Bulgaria, Estonia, France, Ireland, Italy and Spain.
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values’ or ‘reporting delay’. We retrieved literature pub-
lished between 1985 and 2016 (Supplement).
The identified statistical adjustment techniques were 
reviewed for relevance to the EU/EEA HIV surveillance 
data and discussed with the advisory group.
Results
Exploratory analysis
Missing data
In the case-based data analysed, 235,025 of 535,434 
cases (43.9%) had complete information in all of the 
following key epidemiological variables: age, sex, 
transmission category, CD4+  count at diagnosis and 
migration status. These cases were defined as com-
plete cases. Migration status was considered complete 
if one of the following variables was provided: country 
of birth, region of origin, country of nationality.
The low percentage of complete cases was mainly 
explained by CD4+  count, which was only included in 
European reporting as of 2008, as the variable with the 
highest proportion of missing values. The percentage 
of complete cases increased from 25.9% in the pre-
2000 period to 56.8% between 2012 and 2014. This 
corresponded to the improvement in CD4+  count 
availability, which increased from 31.5% among those 
diagnosed before 2000 to 63.1% for the 2012 to 2014 
period (Table 1). Some countries did not provide any 
CD4+  counts (Croatia, Germany, Hungary, Iceland, 
Norway, Poland and Sweden) and some countries were 
only able to report this variable to the EU/EEA dataset 
for more recent years (Estonia, Ireland, France, Slovakia, 
Lithuania, Malta, Denmark, Finland, Lichtenstein, 
Latvia, Belgium, Cyprus and Luxembourg). In these 
cases, CD4+  count is systematically missing either 
overall or for the earlier years.
Migration status could be determined for 87.8% of 
the cases diagnosed during all analysed time periods 
Figure 1
Frequency of missing data in key variables (A) and corresponding missing data patterns (B) in European HIV surveillance 
data, EU/EEA countries (n=31), 2000–2014a
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EEA: European Economic Area; EU: European Union.
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after 2000, compared with 66.0% for those diagnosed 
pre-2000. On the other hand, the proportion of indi-
viduals with known transmission category decreased 
slightly from 89.2% among those diagnosed pre-2000 
to 81.7% for those diagnosed between 2012 and 2014. 
Age and sex were consistently reported in proportions 
higher than 98% during all periods (Table 1).
The patterns of missing data were analysed for the 
cases diagnosed after 2000 (n = 399,477), given the 
higher relevance of the more recent estimates.  Figure 
1  shows the relative frequencies of missing data 
in each key variable. The panel A refers to total 
proportion of the missing values independently for 
each variable, while the panel B demonstrates how 
often the values of the examined variables were 
missing jointly in different combinations. There were 
30 different patterns. Approximately 50% of the cases 
were complete in all key variables, which was the 
most common pattern (Figure 1, panel B). Further, for 
28.0% of cases, CD4+  counts were missing but values 
of all the remaining key variables were available. The 
third row from the bottom in Figure 1, panel B shows 
that in 8% of the cases CD4+  counts, transmission 
category and migrant status is missing, but age and 
sex are available. Various other patterns with lower 
frequencies were also observed, representing 14% of 
the total number of cases.
 
Figure 2  shows the country-specific completeness of 
reporting for CD4+  count, transmission category and 
migrant status. The proportion of complete cases was 
highly variable across countries, ranging from 0 to 
almost 90%, and was mainly driven by the availabil-
ity of CD4+  counts. Missing values in CD4+  cell count, 
transmission category and migrant status tended to 
occur simultaneously. Kendall’s τ ranged from 0.30 to 
0.48 for the three possible pairwise associations of the 
missing value indicators of these variables, suggesting 
that the occurrence of missing values in these variables 
is not completely random.
Reporting delay
We investigated the reporting delay between case diag-
nosis and notification at the national level. The delays 
were the longest for nine countries: Greece, France, 
Italy, Luxembourg, the Netherlands, Poland, Portugal, 
Sweden and the United Kingdom (UK). For 10 countries 
reporting delay was not calculated, either because the 
date of diagnosis was always equal to the date of noti-
fication (seven countries) or because the date of notifi-
cation was not reported (three countries). In reporting 
to TESSy, countries include cases diagnosed during the 
submission year and notified up to a certain, country-
specific date during the subsequent year. The number 
of quarters in the subsequent year for which data are 
still included is the minimal truncation time, which is 
applicable to cases diagnosed during the last quarter 
of the submission year. We considered that a delay is 
relevant in a country if more than 5% of cases are noti-
fied with a delay of two or more quarters in excess of 
the minimal truncation time. In 12 countries, the report-
ing delays were considered less relevant because 95% 
of cases were reported by the minimal truncation time 
(five countries) or within one quarter (three countries) 
or two quarters (four countries) in excess of the mini-
mal truncation time. Although there was no direct asso-
ciation between the size of the country and the length 
of reporting delay, we note that the delay was relevant 
in all large EU/EEA countries, where it could be calcu-
lated, i.e. France, UK, Italy, Poland, and the other large 
countries, Germany and Spain, did not report data nec-
essary for calculation of reporting delay.
Figure 2
Proportion of European HIV surveillance records with 
simultaneous and per variable availability of CD4+ counts, 
transmission category and migrant status by reporting 
country, EU/EEA countries, 2000–2014
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EEA: European Economic Area; EU: European Union.
Simultaneous availability is defined as availability of CD4+ 
counts, transmission category, migrant status, age and sex. For 
some countries the information presented does not cover the 
entire period, as the case-based data were only available for the 
following years: Bulgaria and Estonia (2007−14); Spain, France and 
Ireland (2003−14) and Italy (2010−14).
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Figure 3
Average delay between HIV diagnosis and notification by the quarter of notification and reporting country, eight EU 
countriesa, 2005–2014
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For eight of the nine countries with relevant reporting 
delay, the evolution of the average reporting delay over 
time is shown in Figure 3. Data from Luxembourg were 
not included in Figure 3 due to a low number of cases.
The average reporting delays show peaks in Portugal 
(2013–14), the Netherlands (2010–11) and Poland 
(2010). Furthermore, irregular patterns with occasional, 
less distinct peaks were noted in Italy and the UK.
Assuming that nearly all cases are reported within 5 
years, we analysed cases diagnosed between 2001 
and 2009 to look for patterns that may reasonably be 
expected to continue at later time periods. Data from 
Italy were excluded, as they were only available for 
2010 – 2014.
For cases diagnosed in 2007–2009 the mean report-
ing delay ranged from 0.9 quarters in Greece to 5.6 
quarters in Portugal. Significant changes over time 
were observed in all of the studied countries but 
Luxembourg, with decreasing tendency in all but 
Poland. Other important predictors of the delay dis-
tribution included transmission category and migrant 
status. Notably, the migration status was especially 
important in Luxemburg and Sweden (average delay 
among migrants was 5.8 and 3.3 quarters respectively, 
vs 1.9 and 1.0 quarters in native cases) (Table 2).
Suggested adjustment techniques
Based on our literature search we selected 28 articles 
(including seven reviews) and five textbook passages 
Table 2
Reporting delays for HIV cases by diagnosis date, transmission category and migration status, eight EU countriesa, 
2001–2009
Reporting delay (quarters)b Reporting country
Greece France Luxembourg The Netherlands Poland Portugal Sweden
United 
Kingdom
Date of diagnosis
2001–03 Mean 1.7 2.0 6.9 3.0 0.5 13.1 3.9 3.0
IQR 0–1 1–2 0–6 1–4 0–1 1–21 0–1 0–3
2004–06 Mean 1.2 1.5 5.4 1.5 2.1 9.6 2.6 3.0
IQR 0–1 0–2 0–2 0–1 0–1 1–16 0–1 0–3
2007–09 Mean 0.9 1.3 3.0 1.3 2.0 5.6 1.4 2.3
IQR 0–1 1–2 0–1 0–1 0–1 0–7 0–1 1–3
p value (equality of median) 0.001 < 0.001 0.712 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001
Transmission category
Heterosexual Mean 0.9 1.4 4.2 1.7 1.0 9.5 2.7 2.8
IQR 0–1 0–2 0–1 0–2 0–1 1–15 0–1 0–3
Injecting drug use Mean 2.0 1.6 6.8 3.4 1.0 10.2 1.5 2.7
IQR 0–1 1–2 0–1 0–4 0–1 1–15 0–1 0–3
Men who have sex with men Mean 1.6 1.3 5.4 1.7 1.3 9.3 2.4 2.6
IQR 0–1 0–1 0–8 0–1 0–1 1–14 0–1 0–2
Other Mean 1.2 2.2 10.8 6.8 1.3 12.8 7.3 3.3
IQR 0–1 1–2 0–21.5 1–10 0–1 1–22 0–12 1–3
Unknown Mean 0.6 1.7 8.2 2.2 2.0 10.5 1.9 3.9
IQR 0–0 1–2 0–14 0–2 0–1 1–17 0–1 1–4
p value (equality of median) < 0.001 < 0.001 0.138 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001
Migration status
Originating from the reporting 
country 
Mean 1.3 1.4 1.9 1.4 NAc 9.4 1.0 2.6
IQR 0–1 0–1 0–0 0–1 NA 1–14 0–1 0–2
Originating from abroad Mean 1.0 1.4 5.8 2.4 NA 9.0 3.3 2.7
IQR 0–1 0–2 0–6 0–2 NA 1–13 0–1 0–3
p value (equality of median) 0.06 0.024 0.001 < 0.001 NA 0.518 < 0.001 0.001
Number of inhabitants (in millions)d 11.1 64.4 0.5 16.5 38.1 10.6 9.3 62.0
IQR: interquartile range; NA: not available.
a Greece, France, Luxembourg, Netherlands, Poland, Portugal, Sweden, United Kingdom.
b Medians not presented as they predominantly equal 0.
c Migration status missing for all cases.
d According to Eurostat, 2009 [33].
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discussing the missing values, as well as 27 articles 
(including two reviews) on reporting delay corrections, 
which were relevant to the EU/EEA HIV surveillance 
data (Supplement).
Missing data
When accounting for missingness, one of the following 
mechanisms regarding the missing data needs to be 
considered [3]:
1. data missing completely at random (MCAR), if the 
probability that a value is missing neither depends 
on the value itself nor on any other factors including 
observable covariates;
2. data missing at random (MAR), if the probability that 
a value is missing does not depend on the value 
itself but may depend on other covariates; and
3. data missing not at random (MNAR), if the probabil-
ity that a value is missing may in fact depend on 
the value, which is not observed, e.g. transmission 
category is not recorded as sex between men due to 
possible stigma.
It is not possible to discriminate between MAR and 
MNAR based on the observed data alone. Usually, 
external information is required, for example an expert 
opinion regarding the details of the data collection pro-
cess. On the other hand, the MCAR mechanism is rarely 
encountered and the analysis typically begins with an 
assumption of MAR. A tendency towards simultaneous 
incompleteness of several variables, as was the case in 
the HIV surveillance data (Figure 2), indicates that the 
data are not MCAR.
It is also useful to check if the data follow a monotone 
pattern of missing values. In this pattern, the incom-
plete variables can be ordered so that if the value of 
the first variable is missing then the value of the sec-
ond variable is missing, as well as the values of all 
the following variables. Further, regardless of the first 
variable, if the value of the second variable is missing, 
then the value of the third one and all the following var-
iables are also missing and so on. However, as shown 
in the patterns of missing data in the EU/EEA HIV sur-
veillance data (Figure 1B), monotonicity does not hold.
Typically, the missing value adjustments rely solely 
on the analysed dataset and do not require additional 
data. The simpler techniques, e.g. complete/available 
case analysis, mean imputation and last observation 
carried forward, are prone to various problems, includ-
ing loss of power, bias, dilution of associations and 
underestimation of uncertainty, and should be avoided 
[4]. Moreover, some theoretically grounded techniques, 
Figure 4
Recommended treatment of missing data in EU/EEA HIV surveillance data
Missing data
MCAR MAR
Monotone Non-monotone
MNAR
Systematically
missinga
All variables 
continuous
Some
(or all) variables 
categorical
MVN MI
or  MICE
IPW
or
simple MI
MI
or CCA (with probable 
lack of precision)
MVN MI with 
extensions (Latent 
Variables, General 
Location Model) or MICE
Multilevel MVN MI 
or MICE with GLMs
Sensitivity analysis 
through MI
CCA: complete case analysis; GLM: generalised linear models; IPW: inverse probability weighting; MAR: missing at random; MCAR: missing 
completely at random; MI: multiple imputation; MICE: multiple imputation by chained equations; MNAR: missing not at random; MVN: 
multivariate normal.
a Systematically missing refers to a variable, for which all values are missing, e.g. it is not collected at all in a country.
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such as inverse probability weighting [11], require a 
monotone pattern of missing values (Figure 4). Even 
though the observed pattern of missing values in HIV 
surveillance data at the EU/EEA level is not monotone 
(Figure 1B), this may be the case for national data.
 
The method of multiple imputations (MI), first intro-
duced by Rubin in 1987 [12], has the potential to over-
come the issues outlined above when MCAR or MAR 
mechanisms are valid. The MI method involves filling 
each of the missing values with values randomly sam-
pled from an appropriate distribution. The imputation 
is performed M  times, typically 5– 10, and in effect, 
we obtain  M  so-called pseudo-complete datasets 
[3,4,12]. The model of interest, also called substan-
tive model, can be fitted to each of the imputed data-
sets in order to estimate the parameter of interest and 
its variance  M  times. These can be combined using 
Rubin’s rules [3] to obtain an overall, i.e. average 
over M estimator and its associated variance.
Drawing samples from the distribution of the missing 
data, conditioning on the observed ones to fill in 
missing values, is relatively simple when there is 
only one partially observed variable or for monotone 
pattern, as it involves estimation of an appropriate 
regression model [12]. For non-monotone missing value 
patterns, the main approaches of MI are based on 
joint modelling, e.g. multivariate normal model or full 
conditional specification, i.e. multiple imputations by 
chained equations (MICE) (Figure 4).
The multivariate normal imputation model relies on the 
assumption that the joint distribution of all variables 
under consideration is in fact the multivariate normal. 
For a smaller proportion of missing values, MI may pro-
duce robust results even if this assumption is not met, 
as the imputation model is only applied to the missing 
part of the data [13]. However, in case of a high pro-
portion of missing values, under specific violations of 
multivariate normality and depending on the focus of 
the analysis, the results may be biased [14,15].
More generally, even though there are no clear 
guidelines on acceptable levels of missing values, it is 
expected that any violation of a model’s assumptions 
will have more pronounced consequences with 
high proportions of missing data. In the EU/EEA HIV 
surveillance data, the level of missing values in most 
of the key covariates is below 20% (Figure 1), with 
the exception of CD4+  count. In countries with sparse 
CD4+  data, transformation of CD4+  count to a normal 
distribution should be carefully considered. It would 
also be useful to consider increasing the number of 
imputations beyond the typically used number of 5–10, 
as the estimates can be inaccurate otherwise [16].
If the data contain a mixture of continuous and categor-
ical variables, multivariate normal MI can be extended 
to the latent normal or general location models [17]. 
Alternatively, multiple imputations can be performed 
with the full conditional specification method (MICE) 
(Figure 4). With the MICE method, separate specific 
models are constructed for each of the variables to be 
imputed, depending on the type of these variables. 
These univariate models are fitted iteratively for each 
partially observed variable using both observed and 
previously imputed data of the remaining variables 
until the procedure converges. Then, a pseudo-com-
plete dataset is generated and the whole procedure is 
repeated M  times. MICE offers a flexible way of speci-
fying the imputation models. However, the risk of this 
procedure is that the specified models may be incom-
patible, i.e. no joint model for which the conditional 
models would be described by the proposed univariate 
models exists [18,19].
Both the joint modelling and the full conditional speci-
fication approaches described above can be extended 
to datasets combining data from different studies or, as 
is the case with EU/EEA HIV surveillance data, different 
national surveillance systems [20,21]. The approach 
proposed by Quartagno et al. [20], which is based on 
multilevel multiple imputation and incorporating the 
idea of random covariances, and the approach of Jolani 
et al. [21], which applies generalised linear mixed mod-
els within the MICE framework, would also allow for 
imputation of covariates in national data in the coun-
tries where these covariates are completely missing, 
using other countries’ data in the EU/EEA surveillance 
dataset.
Importantly, all MI methods rely on the assumption that 
data are MAR. Although this is a plausible assumption, 
and rich imputation models increase the likelihood of 
satisfying it [22], one needs to assess the extent to 
which the data support the analysis conclusions under 
a range of scenarios of violations of the MAR assump-
tion. Sensitivity analyses on the plausibility of the MAR 
assumption can be performed either within a pattern 
mixture model framework or in a simpler approximate 
method based on the idea of up-weighting imputations 
that are more likely under an MNAR mechanism [23].
Reporting delay
Reporting is often considered in discrete time frame-
works, e.g. years, quarters, months, and, typically, 
the same time units are used to describe the reporting 
delay. With EU/EEA HIV surveillance data, the conven-
tional time unit is one quarter. The majority of modern 
adjustment techniques rely on estimation of the delay 
distribution independently of the diagnosis rate [24-
26]. Once the estimate for the delay distribution is 
obtained, it is used to estimate the proportion of cases 
already reported, given the diagnosis date and the cut-
off date for reporting, i.e. truncation time. Estimating 
this proportion allows for adjusting the diagnosis rate.
The reporting delay distribution can be estimated 
in a non-parametric way using a multinomial model, 
assuming there is a maximum delay [5], or using the 
reverse time transform and estimating the survivorship 
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function with left-truncated data [27]. In practice, 
both the confidence intervals and the point estimates 
for the delay probabilities are equivalent for the two 
approaches. Alternatively, missing data techniques, as 
discussed above, could be applied. Using these meth-
ods, the counts of the cases, which will be reported 
with delay, are treated as missing and imputed [28].
A fully non-parametric estimation allowing arbitrary 
trends of the delay distribution over time is not pos-
sible. Therefore, additional assumptions have to be 
made: that the delay distribution is not changing over 
time, the so-called quasi-stationarity assumption, 
or that it is stable in time intervals, or that the trend 
can be described by a regression model [24,26,29]. 
Regression models also offer a convenient way to 
test the quasi-stationarity assumption [29] and pos-
sibly simplify the estimation if this assumption is 
reasonable.
The overriding issue in estimation of the delay dis-
tribution is the right truncation. However, double 
truncation, i.e. left and right truncation, may apply 
to countries with long reporting delays where surveil-
lance was implemented with delay and data on ear-
lier diagnoses may not be available. The methods for 
non-parametric estimation in such instances are more 
complex and may not be available in standard statisti-
cal packages [30,31]. An interesting alternative to fully 
non-parametric models is to model the hazard function 
parametrically, choosing appropriately flexible func-
tions such as splines [6]. Finally, some methods have 
already been developed to account for random varia-
tion of the reporting delay, e.g. a multinomial model 
with random effects [5].
Discussion
The exploration of data quality issues in the EU/EEA 
HIV surveillance data showed that both missing data 
and reporting delay were present to varying degrees 
across countries and over time. Addressing these 
issues requires the application of proper adjustment 
techniques and clear understanding of national data in 
order to optimise the validity of estimates derived from 
these data.
Considering the complex nature of missing data in the 
EU/EEA HIV surveillance data, the lack of monotonicity 
in the missing data patterns, the high likelihood of MAR 
or even MNAR mechanisms and the variety of potential 
analyses of interest, multiple imputation methods 
seem to provide an optimal framework for inference 
[3,4]. Joint modelling and full conditional specification 
[18,19] approaches are flexible and mature enough to 
accommodate even complex analyses. Their potential 
for multilevel extensions [17,20,21] might prove very 
useful when combining evidence across EU/EEA 
countries, especially for countries with systematically 
missing CD4+ counts. Moreover, MI methods offer a very 
flexible framework for sensitivity analyses regarding 
the possibility of non-random missingness [23].
The reporting delays encountered in the EU/EEA HIV 
surveillance data were noteworthy only for a fraction 
of the countries. However, among these countries we 
noted marked differences with respect to the average 
delay, observable trends over time and differences 
between subpopulations. Moreover, in several coun-
tries the average reporting delays are much higher for 
selected notification quarters. These increases are 
possibly related to control activities in surveillance, 
‘cleaning events’ during which previously unreported 
cases are discovered and notified with delay. In other 
countries irregular patterns are observed, which could 
be related to random situations that may occasionally 
delay the notification process, including at local levels. 
Certainly though, in particular situations, other mecha-
nisms may result in similar data patterns.
The reporting delay correction method introduced in 
the EuroHIV project, which coordinated HIV/AIDS sur-
veillance in the WHO European Region between 1984 
and 2007, and applied also by the ECDC, assumes that 
the delay distribution remains stationary [8,9]. This is 
not the case in all countries. Appropriate country-spe-
cific regression models, accounting for right truncation 
of data, which allow to include the trends in reporting 
delays along with other predictors, should therefore 
be considered [8,24,27,29]. Two particular issues that 
may require special treatment are (i) the long tails of 
the delay distributions, which are problematic when 
the data are not available from the start of an epidemic 
(e.g. Italy) and (ii) extra-variability because of fluctua-
tions of reporting systems (e.g. UK, Italy) or control 
events (e.g. Portugal, Poland, the Netherlands). The 
former can be dealt with by using the methods for dou-
bly truncated data [6,30,31]. The random fluctuations 
of the surveillance systems may be approached via 
random effect models [5]. However, the problem of the 
cleaning events may still pose a challenge.
There is a clear need both to improve the quality of 
surveillance data at the systems level and to employ 
statistical procedures to reliably adjust estimates and 
quantify their uncertainty. At the time of consultation 
in 2015, only three countries (France, Spain and the 
UK) reported routinely using statistical corrections in 
line with those mentioned in this study [9,32]. This 
may suggest a lack of capacity in some countries to 
apply these methods. The wider use of the adjust-
ments would not only improve the national estimates, 
but also contribute to higher comparability and har-
monisation of data across EU/EEA. We therefore rec-
ommend applying these adjustments for national 
estimates, preceded, if needed, by capacity building at 
the national level. Usage of the adjustments requires 
careful considerations because of the complexity of 
the data and their heterogeneity across countries and 
over time. Importantly, some variables are collected in 
national surveillance systems that are not later on for-
warded to the EU/EEA surveillance system even though 
10 www.eurosurveillance.org
these variables may be essential to effectively correct 
for the missing data and reporting delay.
The next steps, in terms of refining and optimising the 
identified techniques, include the application and vali-
dation of several generic models, taking into account 
particular covariates collected in the surveillance sys-
tems to guide future use of these techniques at national 
or EU/EEA level.
Furthermore, as data incompleteness and delay in 
reporting are by no means unique to HIV surveillance, 
the adjustment techniques discussed here may also be 
applicable to other surveillance systems with similar 
data quality problems.
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